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Purpose: The cytotoxic effects of hexane extracts of Cassia alata and Psidium guajava  leaves were 
evaluated in OV2008 ovarian and Kasumi-1 leukemia cancer cell lines, respectively.  
Methods: The cancer cells were exposed to various concentrations of either C. alata (100 – 180 µg/ml) 
or P. guajava (100 – 500 µg/ml) leaf extract for 24 h. Following treatment, the cells were evaluated using 
the 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay to determine the cytotoxic 
effect of the extracts. C. alata extract was also analyzed using high performance liquid chromatography 
(HPLC). 
Results:  C. alata and P. guajava extracts produced significant (p < 0.05) cytotoxicity in OV2008 and 
Kasumi-1 cell lines, respectively. The IC50 values were 160 µg/ml for C. alata and 200 µg/ml for P 
guajava. Further, the cytotoxicity exhibited by C. alata might be attributable to the flavonoid, kaempferol, 
which was identified as a constituent of the extract. 
Conclusion: The results suggest that further chemical analysis and mechanistic investigations   should 
be conducted on P. guajava and C. alata extracts to validate their potential uses for anticancer therapy. 
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INTRODUCTION 
 
Psidium Guajava (P. guajava) is a plant 
belonging to the family Myrtaceae and is 
native to tropical America [1].  In ethno-
traditional medicine, extracts of the root, bark 
and leaves of P. guajava have been used to 
treat a wide range of illnesses such as 
gastroenteritis, vomiting, diarrhea, dysentery, 
wounds, ulcers, coughing and hyperglycemia 
[1]. A limited number of studies have reported 
cytotoxic activities of P. guajava in prostate 
[2,] and breast [4] cancer cells. There is, 
however, need for validation of the cytotoxic 
activity of the plant in other types of cancer 
cells.  
 
Cassia alata (C. alata) is a plant from the 
family Caesalpiniaceae which has been used 
traditionally in herbal medicine for the 
treatment of conditions such as constipation 
and various skin diseases [5,6] in countries 
such as Indonesia, Bangladesh, Philippines 
and Jamaica [7,8]. There is a deficiency of 
information regarding the traditional use of C. 
alata for cancers, but compounds from C. 
alata have been reported to exhibit anti-
angiogenic activity and cytotoxic activity in 
breast cancer cell lines [9] as well as 
protective effects against pancreatic cancer 
[10]. The available scientific evidence to 
support cytotoxic activities of C. alata in 
cancers such as ovarian cancer is lacking 
and this has propelled the present study.  
 
Cancer of the ovary is the seventh most 
frequent cancer in women worldwide [11] and 
the leading cause of gynecologic cancer-
related death in Europe and the USA [12]. In 
Jamaica, for the period 2003 - 2007, the 
incidence of ovarian cancer was 4 .6 per 
100,000 per year, and is ranked 8th among 
cancers in women [13]. Leukemia is the 
leading type of cancer in children aged 0 - 14 
years in Jamaica, specifically Kingston and 
St. Andrew [14] and the 7th and 10th most 
common cause of cancer death overall in 
men and women, respectively, in the world 
[15].  
 
Current pharmacological management of 
leukemias, such as acute myeloid leukemia 
(AML), involves the use of cytarabine plus an 
anthracycline as mainstay therapy [16], while 
standard primary therapy for ovarian cancers 
is carboplatin and paclitaxel [17]. The 
limitations of these current conventional 
therapies used in the treatment of ovarian 
cancers and leukemias have in recent years 
contributed to a significant increase in the 
targeted screening of plant materials for 
cytotoxic activities. Such limitations include  
the severe unwanted effects, drug resistance 
and relapse that usually accompanies 
chemotherapy of leukemias[18] and ovarian 
cancers [17], and the postulation that 
ethnopharmacologically derived therapies 
might represent a safer modality of treatment. 
 
For our investigations, we used the OV2008 
ovarian and the Kasumi-1 leukemia (AML) 
cell lines which are commonly used in 
cytotoxicity screening protocols. Our study is 
the first to evaluate the cytotoxic effect of 
hexane extracts of C.alata and P. guajava 





Plant material  
 
The P. guajava and C. alata plants were 
obtained from the parishes of Kingston and 
Clarendon in Jamaica, respectively. They 
were authenticated by Mr. Patrick Lewis at 
the herbarium of University of the West Indies 
(UWI) Mona Campus, Jamaica. Voucher 
specimens (#35349 for C. alata  and #35449 
for P. guajava) were also deposited at the 
herbarium. The leaves of both plants were 
washed with water.  P. guajava leaves were 
dried using a solar drier and C. alata leaves 
were air-dried for approximately 7 days. The 
dried leaves of P. guajava were milled to a 
fine powder. 
 
For extraction, C. alata leaves were dried and 
homogenized in methanol (100 g in 1000 ml 
methanol). The extract was filtered and 
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concentrated in vacuo using a rotary 
evaporator. The methanol (Sigma Aldrich, 
USA) fraction was then partitioned between 
hexane (Sigma Aldrich, USA) and water (1:1 
v/v) The hexane fraction was then 
concentrated in vacuo and stored at 4 ºC for 
further studies. 
 
Sixty grams of P. guajava leaf powder was 
placed in a separating funnel and 500 ml of 
hexane (Sigma Aldrich, USA) was added to 
it. The mixture was then allowed to stand for 
4 days.  Subsequently, the hexane extract 
was concentrated in vacuo and the remaining 




OV2008 cancer cells were kindly donated by 
Stupack Lab from the Moore’s Cancer 
Center, UCSD, California, USA. Kasumi-1 
cells were purchased from American type 
Cell Culture Collection (ATCC). OV2008 cells 
were propagated in 90 % Dulbecco's 
Modified Eagle's Medium (DMEM) containing 
10 % fetal bovine serum (FBS) and 1 % 
penicillin/streptomycin.  Kasumi-1 cells were 
cultured in RPMI-1640 medium 
supplemented with 20 % FBS and 1 % 
penicillin/streptomycin. All the cells were 
cultured at 37 °C in a humidified atmosphere 
of 5 % CO2.  All culturing reagents were 
purchased from Thermo Scientific, USA. 
  
Trypan blue exclusion assay for cell 
viability 
 
The trypan blue exclusion assay was used to 
determine the viability of each cell line before 
the treatment of the cells with extracts. 
Briefly, 200 µl of each cell suspension was 
removed and mixed with an equal volume of 
0.4 % trypan blue solution (Sigma Aldrich, 
USA). After incubation at room temperature 
for 5 min, the number of unstained (viable) 
and stained (non-viable) cells were counted 
using a hemocytometer. Cell viability (V) was 
calculated using Eq 1. 
 
V = (Cv/Ct) x 100 ………………… (1) 
 
where Cv is viable cell number and Ct total 
cell number. 
 
MTT cytotoxicity assay 
 
The cytotoxic activity of C. alata extract was 
assessed in OV2008 cells, while that of P. 
guajava extract was assessed in Kasumi-1 
cells by MTT assay (Bioassay Systems). 
Cells were plated in 96-well plates (5 x 104 
cells per well) in triplicate and incubated 
overnight at 37 °C. After 24 h, the extracts 
were added from a stock diluted to 
concentrations ranging from 100 to 180 µg/ml 
for C. alata and 100 - 500 µg/ml for P. 
guajava using dimethyl sulphoxide (DMSO, 1 
%, 1000 µl, Sigma Aldrich, USA) and then 
serum free DMEM media at volumes ranging 
from 500 - 900 µl for P. guajava and 820 – 
900 µl for C. alata.  Final DMSO 
concentration was < 0.1 %. A volume of 20 µl 
of each concentration of C.alata or P. 
guajava extract was added in triplicate to 
selected wells, respectively. Control wells 
received media only (20 µl) in triplicate. The 
cells were then incubated for 24 h. Following 
incubation,  
15 µl of the MTT labeling reagent was added 
to each well and incubated in a humidified 
atmosphere at 37 °C for 4 h. Following 
incubation, 100 µl of the solubilizing reagent, 
sodium dodecyl sulfate (SDS, 10 %) was 
added to each well and mixed gently for 1 h 
at room temperature. The absorbance of 
each well was measured at 540 nm using an 
ELISA reader (Lab Systems) and percent 
viability calculated. The mean extract 
concentration that was cytotoxic to 50 % of 
the cells (IC50) was calculated from multiple 
runs.  
 
HPLC analysis of C. alata extract 
 
One milligram of C. alata extract was 
dissolved in methanol and injected into the 
HPLC system. The HPLC detection system 
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used was a Prostar 325  UV-Vis Detector. 
The samples were injected into LUNA C18 
column (5 um particle size, 4.6 × 250 mm, 
Phenomenex, USA). The mobile phase 
consisted of acetonitrile/methanol/ammonium 
acetate (pH 6.8) in the ratio 25:55:20 (v/v/v) 
and at a flow rate of 0.5 ml/min. All 
chromatographic procedures were performed 
at 25 °C; the peaks were detected at 260 nm. 
Standard solutions of kaempferol (Sigma 
Aldrich, USA) were prepared at 5.0, 10.0, 
25.0, 50.0 and 100.0 ug/ml by diluting with 
methanol. A sample size of 10 ul was injected 




The results of each series of experiments 
(performed in triplicates) are expressed as 
the mean values ± standard deviation (SD). 
Statistical significance of the data was 
determined using the independent t-test; a 
value of p < 0.05 was accepted as 
statistically significant. Sigma plot software, 
version 10 (Systat Software, Inc., Richmond, 





Trypan blue viability assay 
 
The viability of the OV2008 cell line was 
determined to be 95% and the viability of the 
Kasumi one cell line was determined to be 
96%.  
 
Cytotoxic effect of C. alata extract on 
OV2008 cells 
 
Figure 1 depicts the dose-dependent 
cytotoxic effect of the C. alata extract on 
OV2008 cancer cells. The cells were 
exposed to concentrations of 100, 120, 140, 
160 and 180 µg/ml of C.alata extract for 24 h. 
Viability in C. alata treated cells was 
significantly (p < 0.05) lower than in untreated 
controls. IC50 of the C. alata extract was 




Figure 1: Cytotoxic effect of C.alata extract on 
OV2008 cells  (mean ± SD (error bars , n = 3); *p 
< 0.05; **p < 0.005)  
 
Cytotoxic effect of P. guajava extract in 
Kasumi-1 cancer cells 
 
Figure 2 depicts the dose-dependent 
cytotoxic effect of the P.guajava extract on 
Kasumi-1 cancer cells.  The cells were 
exposed to concentrations of 100, 200, 300, 
400, 500 µg/ml of P. guajava extract for 24 h. 
Viability in P. guajava treated cells was 
significantly (p < 0.05) lower than in untreated 
controls. IC50 of the P. guajava extract was 
determined to be 200 ug/ml. 
 
Chromatogram of C. alata extract and 
kaempferol standard 
 
The peak for kaempferol in the C. alata 
extract (Figure 3a) was identified by 
comparing the relative retention time (RRT) 
with that of the chemical standard kaempferol 
(Figure 3b). The relative retention time (RRT) 
were 6.895 (Peak-1) and 6.882 (Peak-2) 
minutes for extract and standard, 
respectively. 
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Figure 2: Cytotoxic effect of P. guajava extract in 
Kasumi-1 cells  (mean ± SD (error bars , n = 3); *p 





Figure 3: HPLC chromatograms of C. alata extract 





A trend towards increased screening of plant 
derived material for anti-cancer activity has 
been rapidly developing in recent years. 
Generally, driven by the ethno-traditional 
uses of different herbal remedies, the 
screening of plant extracts for cytotoxic 
potential towards cancer cells is usually 
accomplished by routine colorimetric assays 
such as the MTT assay. The MTT test 
produces sufficient preliminary data to 
confirm or discredit the ability of an extract to 
kill cancer cells and as such will validate the 
need for further studies. 
 
In the present study, P. guajava extract 
demonstrated significant cytotoxic activity in 
the Kasumi-1 leukemia cancer cells. The IC50 
of 200µg/ml obtained in our study was 
comparable to the IC50 of 250 µg/ml obtained 
by Chen et al [19] in the human prostate 
carcinoma DU-145 cell line treated with 
aqueous P. guajava extract.  It has been 
suggested that this anti-cancer activity may 
be due to the presence of polyphenolic 
compounds such as gallic acid and 
flavonoidsin the extract [19]. Although a 
hexane extract of the leaves was used in our 
study, gallic acid as well as flavonoids such 
as quercetin and kaempferol have also been 
identified in hexane extracts of P. guajava 
leaves [20]. Further, both kaempferol and 
quercetin have been reported to exhibit 
cytotoxic activities in various cancer cell lines 
[21]. Therefore, the cytotoxic activity of P. 
guajava extract against kasumi-1 cells could 
be attributed to the presence of these 
compounds. In further studies we will 
examine the chemical constituents of the 
extract to substantiate this claim.  
 
The C. alata extract used in our study also 
showed significant cytotoxic acitivity in OV 
2008 cancer cells. These preliminary results 
could be justified by the cytotoxic activity of 
the flavonoid, kaempferol, which is present in 
C.alata species [22]. The cytotoxic activity of 
kaempferol has been reported in other 
ovarian cancer cell lines [23]. Preliminary 
analysis of our C.alata extract using HPLC 
identified kaempferol as a constituent of the 
leaf extract (Figure 3). While the compound 
rhein from C. alata has been shown to inhibit 
the viability of MCF-7 and MDA-MB-435s 
breast cancer cells [9], our study is the first to 
report the cytotoxic activity of crude C. alata 
extract in a cancer cell line such as OV2008. 
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The implication of these results is noteworthy 
in the light of the fact that plants have for a 
long time been a copious source of 
therapeutic agents for the treatment of 
cancers [24]. The Caribbean Herbal 
Pharmacopeia, however, is quite diverse, and 
there is still a significant number of medicinal 
plants whose entire active constituents have 
not yet been fully investigated [25] . 
Therefore, in further studies we intend to 
elucidate the mechanism via which both C. 
alata and P. guajava extracts produced 
cytotoxicity in these cancer cells and to 
characterize the bioactive chemical principles 
in each extract via activity-directed 
separation. We will examine apoptosis as a 
route by which the extracts might be inducing 
cell death since generally, compounds rich in 
flavonoids and other phenolics have a 
tendency towards activation of the apoptotic 
pathway [26 ].  Furthermore, kaempferol has 
been shown to induce apoptotic death of 





C. alata and P. guajava leaf extracts exhibit 
cytotoxic activity in OV2008 and Kasumi-1 
cells, respectively. The results suggest that 
further chemical analysis and investigations 
of mechanisms should be conducted on both 
extracts to elucidate active chemical 
principles and to validate their potential uses 
for anticancer properties. Such properties 
could be of significant therapeutic and 
economical value, especially in countries 
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